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Several products ofCTL andNK cells, including a pore-forming protein (PFP ;t
perforin or cytolysin) (1-4)and several serine esterases (SE) (5-12), have been cloned
and sequenced . These proteins are localized to cytoplasmic granules and represent
the known structural components ofthepore-formationandgranule exocytosis models
forcell-mediated killing (13-17). Granule mediators areexpressed by CTL andNK
cell linesmaintained with IL-2, but there is still little informationonprimaryeffector
lymphocyte populations . Moreover, to date, most ofthe studies have been performed
in the murine system . Here, usingcDNA probes encoding two SE (SE 1/granzyme
A/Hanukah Factor and SE 2/granzyme B) and the recently cloned perforin cDNA,
we have initiated studies aimed at understanding how the production of these pro-
teins is regulated in human primary T lymphocytes . We have examined RNA ac-
cumulation in response to a number of well-knownT cell mitogens and have deter-




Lectins Con A and PHA, and PMA, were purchased from Sigma Chemical
Co. (St. Louis, MO). Restriction endonucleases were obtained from United States Biochem-
ical Corp. (Cleveland, OH). CsA and an immunologically inactive analogue CyclosporinH
(CsH) were obtained from Sandoz Co. (Basel, Switzerland) . Human rIL-2 was generously
provided by Biogen (Cambridge, MA) and Cetus Corp . (Emeryville, CA).
cDNA probes were obtained as follows . Granzyme B (a 0.9-kb Eco RI segment) and actin
(an EcoRI-Xho Isegment) wereobtained as described (8) ; granzymeA(a 0.9-kbEcoRI-Barn
HI segment) was generously provided by Dr . I . L. Weissman of Stanford University, Palo
This work wassupported in part by grants from theAmerican Cancer Society (New York City Divi-
sion), the Cancer Research Institute/Frances L.and Edwin L.Cummings Memorial Fund Investigator
Award, the American Heart Association (New York City Affiliate), the Irvington Institute for Medical
Research, and the National Institutes of Health (CA-47307, AI-24775, CA-30198, and GM-37643) .
C.-C . Liu is a Fellow ofthe Irvington Institute . J . A. Trapani is supportedby aC.J. Martin Travelling
Fellowship, NIH (CA-49096, CA-22507, andCA-08748), a grant fromXOMA Corporation, CA, and
the Medical Research Council, Australia. J . D.-E Young is a Lucille P Markey Scholar .
Address correspondence to Dr. Chau-Ching Liu, Laboratory ofCellular Physiology andImmunology,
Box 208, The Rockefeller University, 1230 York Ave., New York, NY 10021 .
1 Abbreviations used in thispaper . CsA, CyclosporinA; CsH, CyclosporinH; IT, lymphotoxin; PFP, pore-
forming protein ; SE, serine esterase.
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Alto, CA (11); human TNFa/cachectin (a 300-b Pvu II fragment) and lymphotoxin (LT or
TNF(3) (a 950-b Eco RI segment) were obtained from Dr. Michael Sheppard, Genentech
Inc., South San Francisco, CA (18).
Cell Lines.
￿
Human T cell lines MOLT4, GEM, HPB-ALL, HUT 78, and RPMI-8402,
erythroleukemia cell line K562, promyelocytic leukemia cell line HL-60, histiocytic leukemia
cell line U937, B lymphoma cell line NALM-16, and Burkit lymphoma cell line Raji were
obtained from the American Type Culture Collection (Rockville, MD). The B lymphoblastoid
cell lines, COX, DBB, IM-9, and MANN have been characterized and described elsewhere
(19, 20). SK007 is a human plasma cell line.
PBL.
￿
Human PBMC were obtained from buffy coats of normal donors (New York Blood
Center, New York) by Ficoll-Hypaque gradient centrifugation. To enrich for T lymphocytes,
PBMC were subjected to plastic adherence and passage over nylon wool columns to deplete
monocytes and B lymphocytes. Monocyte-depleted PBL or nylon wool-enriched T lympho-
cytes were each cultured at 5 x 106 cells/ml in RPMI 1640 (Gibco Laboratories, Grand Is-
land, NY) supplemented with 5% FCS (Gibco Laboratories), and different mitogens: PMA
at 10 ng/ml, Con A at 5 1~g/ml, PHA at 20 kg/ml, or rIL-2 at 100 U/ml. At the indicated
times, cells were washed and subjected to RNA extraction. T lymphoblasts were prepared
as described in detail elsewhere (21). Briefly, PBMC were cultured at 2 x 106 cells/ml in
medium containing 2 ug/ml of PHA for 4-5 d. The T blasts were collected, washed, and
cultured in medium in the presence or absence of stimulants as described above.
Subpopulations of T lymphocytes were further fractionated by negative selection using
a panning technique. Cells were incubated with the mAbs that recognize cell surface mole-
cules CD4 (OKT4), CD8 (OKT8), or CD11b complement receptor (OKMI), respectively,
for 1 h on ice. Cell supernatants ofhybridomas OKT4, OKT8, and OKMI hybridoma (Amer-
ican Type Culture Collection) were used at a 1 :3 final dilution. Cells were washed three times
and the antibody-coated cells were centrifuged onto plastic dishes coated with goat anti-mouse
Ig (Organon Teknika-Cappel, Malvern, PA). Nonadherent cells were removed and reapplied
to new coated dishes two more times. After the third round of panning, cells were cultured
with various mitogens for the indicated times before RNA extraction. Homogeneity of cell
populations obtained by this panning procedure was ascertained by cytofluorographic anal-
ysis (FAGS), which revealed undetectable levels ofthe phenotypicmarkers against which cells
had been negatively selected in the panning procedure. Plastic-adherent cells were used as
accessory cells at the ratio of 1 :5 (one accessory cell equals five T cells).
Blood samples from a patient having marked elevation in peripheral bloodlarge granular
lymphocytes were obtained from Dr. M. Andreeff(Memorial Hospital for Cancer and Allied
Diseases, New York). 80% of PBMC from this patient were phenotypically NK cells (Leu-
11', Leu-19'), as judged by cytofluorographic analysis. After culture of these PBMC in
medium containing rIL-2 at 50 U/ml, >98% of these cells were of the NK phenotype. These
cells were used in Fig. 1 (last two lanes). Allogenically stimulated bulk lymphocyte popula-
tions were derived from an MLC using PBL from two HLA-unmatched healthy donors. The
MLC-derived cells were periodically restimulated with the corresponding allogeneic cells and
expanded in IL-2-containing medium as above (material used for Fig. 1, first lane).
cDNA Clonefor Human Perforin.
￿
A cDNA library of MLC-derived human lymphocytes
was constructed in bacteriophage Xgt11, as described elsewhere (8) . The library was screened
by plaque hybridization using a 33-base oligonucleotide probe, CTTGCACTCT
GAGCGTGCGGCTGTGTGGCACGG (5' to 3'), which is complementary to nucleotides
63-96 ofa published cDNA sequence of human perforin (2). The clones that hybridized with
this probewere plaque purified and subcloned into the plasmid vector pUC18. A clone (desig-
nated HP-10) with a 2.5-kb insert encoding the full-length human perforin was used in all
subsequent experiments. Plasmid DNA containing HP-10 was sequenced by the dideoxynucleo-
tide chain termination method (22).
Southern (DNA)BlotAnalysis.
￿
Genomic human DNA was prepared and digested with var-
ious restriction enzymes. 10 Rg of digested DNA was fractionated through a 0.7% agarose
gel and capillary transferred to a nylon membrane (Micron Separations Inc.). Prehybridiza-
tion and hybridization were conducted at 42°C in 50% formamide, 5 x Denhardt's (1 x Den-
hardt's: 0.02% BSA, 0.02 % Ficoll, 0.02% polyvinylpyrrolidone), 5 x SSC (1 x SSC : 0.015LIU ET AL.
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M Na Citrate, 0.15 M NaCl, pH 7.0), 1% SDS, and 100 pg/ml of salmon sperm DNA, for
3 and 16 h, respectively. The cDNA probe was nick-translated using a-[s2p]dCTP (New En-
gland Nuclear, Boston, MA). After hybridization, the blot was washed twice with 2 x SSC/0.1
SDS at room temperature for 15 min, followed by two 15-min washes with 0.5 x SSC/0.1
SDS at 60°C. The autoradiogram was exposed at -70'C for 3 d with intensifying screens.
Northern (RNA)Blot Analysis.
￿
10 p,g of total cellular RNA or 1 jig of poly(A)' RNA was
isolated using a modified guanidinium isothiocyanate/CsCl method (23), fractionated on 1
agarose-formaldehyde gels, transferred to GeneScreen Plus membrane (New England Nu-
clear), and probed with 32P-labeled probes. The blots after hybridization were washed two
times with 2x SSC/1% SDS at room temperature for 15 min, followed by two washes with
0.5 x SSC/1 % SDS at 600C. Autoradiography was performed with intensifying screens for
12 h to 5 d. In some experiments, the signal intensities obtained with perforin, SE 1, and
SE 2 were normalized against the intensity seen with actin cDNA probe.
Results
Isolation ofa Human Perforin cDNA Clone.
￿
A cDNA library was constructed from
human T lymphocytes stimulated in the MLC, and the library was screened with
an oligonucleotide probe complementary to a published sequence of human per-
forin (2). Of five positive clones, one, designated HP-10, was sequenced. HP-10 con-
tains a 2.5-kbinsert that includes a poly(A) stretch preceded by the consensus poly-
adenylation signal AATAAA. 700 bases of HP-10 were sequenced and were shown
to be identical to those published elsewhere (reference 2; data not shown). The se-
quence information indicates that HP-10 encodes for full-length human perforin with
extension of noncoding region in both 5' and Tends. Southern blot analysis of human
genomic DNA with HP-10 showed that human perforin is encoded in a single locus
in the human haploid genome (not shown). Perforin coding sequences were con-
tained within 10 kb of genomic DNA.
To verify the cellular distribution of the cloned perforin transcript, Northern blot
analysis was conducted on activated lymphocyte populations and on a panel ofhuman
cell lines (Fig. 1). HP-10 hybridized with a unique 2.9-kb mRNA species from allo-
genically stimulated, IL-2-expanded T lymphocytes (Fig. 1, first lane) and NK cells
obtained from a leukemic patient (Fig. l, last two lanes), which effectively kill appro-
priate allogenic target cells and K562 cells, respectively. Perforin mRNA levels in-
creased in NK leukemia cells after culture with rIL-2 for 20 d (Fig. 1, compare the
last two lanes). These same cell populations contained mRNAs for SE 1, SE 2, and
actin (Fig. 1). Actin was used as an internal control for all the Northern blots since
minimal changes in actin RNA were observed in response to cell stimulation with
mitogens. After short-term treatment of NK leukemia cells with rIL-2, the mRNA
level for SE 1 was more pronouncedly increased (5.6-fold when compared with non-
stimulated NK leukemia cells) than that of SE 2 (2.7-fold). Of the 16 noncytotoxic
human cell lines tested, only HUT78, an HTLV1-transformed T lymphoma cell
line, produced low levels of perforin mRNA, and none produced detectable levels
of SE 1 or SE 2 mRNAs.
InductionofPerforin andSEin PrimaryLymphocyte PopulationsandEfects ofCsA.
￿
PBL
from healthy donors were stimulated with several mitogens single or in concert. As
shown in Fig. 2, resident T cells expressed little or no mRNAs specific for perforin,
SE 1, or SE 2. The addition of rIL-2 at 100 U/ml (Fig. 2 A), or a combination of
lectin (Con A or PHA) and PMA (Fig. 2 B), induced all three mRNAs. mRNA2108
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FIGURE 1 .
￿
RNA blot analysis to verify cell-type distribution ofhuman perforin and SE . Lanes
contain poly(A)' RNA (1 ftg per lane) and were hybridized with probes specific for PFP/per-
forin, SE 1, SE 2, and actin . The same blot was rehybridized with several cDNA probes . MLC-
IL-2 represents a bulk (i .e., uncloned) culture ofallogeneically stimulated, IL-2-expanded human
PBMC . Lp represents the cells ofa patient with amarked leukocytosis involvingNK cells (Materials
and Methods) . Lp-IL-2RNAwas derived from thesame cells culturedwith rIL-2 for 20d . Auto-
radiography was performed for 3 d .
induction by either rIL-2 or a combination ofPMA and lectin followed different
time courses (compare Fig . 2, A and B) . Perforin and the two SE were quickly in-
duced by rIL-2 (100 U/ml) : low levels ofmRNAswere detected 4h after stimulation,
peakmRNA levels occurred at 12-24 h, and thereafter, themRNA levels decreased .
In contrast, the combination ofPMA and lectin caused a slower accumulation of
mRNA levels for all three transcripts, taking 12-24 h for mRNAs to be detected
and 48-72 h to peak . The extent ofmRNA accumulation for all three transcripts
was augmented with increasing doses of rIL-2, as shown in Fig . 3 . For perforin,
as little as 10 U/ml of rIL-2 resulted in increasedmRNA levels after 12 h of treat-
ment, whereas induction ofSE 1 and SE 2 mRNAs required higher doses of rIL-2.
Forthe two SE, we observed that, in general, SE 1 levels were upgradedmore readily
by IL-2, while SE 2 appeared to respond better toacombination oflectin plusPMA;
however, this conclusion could not be generalized, as PBL from individual donors
showed marked variability (see Fig. 2 B for example) .
Lectin-primedT cells (T blasts)had previously been shown to be auseful source
for studies of the control of several T cell mRNAs (21). We first verified whether





Induction ofperforin andSEmRNAs in PBL . HumanPBL derived from buffy coats
ofnormal donors were stimulated with 100U/ml of rIL-2 (A) or 10 ug/ml ofCon Aand 10 ng/ml
ofPMA(B) for the indicated periods oftime. 10,ug oftotal cellularRNA in each lane was resolved
on the agarose gel and analyzed sequentially with cDNA probes specific for PFP/perforin, SE
1, SE 2, and actin . The autoradiograms in A were exposed for 1 d . The autoradiograms in B
were exposed for 7 d, with the exception, however, ofthe blot hybridized with actincDNA,which
was exposed for 1 d .
those established for unprimed populations (Fig. 4) . Perforin mRNA was detected
in most T blast populations examined . IL-2 alone, or a combination of lectin and
PMA, further increased perforin mRNA levels . SE 1 and SE 2mRNAs were simi-
larly upregulated . In the experiment shown in Fig . 4, SE 1 responded well to IL-2
FIGURE 3 . Dose-dependent induction of
human perforin and SE mRNAs by rIL-2 .
Human peripheral bloodTlymphocytes were
cultured for 12 h in the presence of the indi-
cated amounts of rIL-2 . Total cellular RNA
(10 ug per lane) was extracted and analyzed
byRNA blot analysis usingcDNA probes for
the indicated transcripts . Theautoradiogram
was exposed for 24 h .2110
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FIGURE 4 .
￿
RNAblot analysis of expression of human perforin, SE, TNF, and IT mRNAs in
T lymphoblasts . PHA-primed T lymphoblasts were prepared as described in Materials and
Methods . The blasts were stimulated for 10 or 20 h with rIL-2 (100 U/ml) and 1'6 h with PHA
(10 ug/ml) plus PMA (10 ng/ml) . In the same experiments, someT lymphoblasts were stimu-
lated, as described above, in the presence ofCsA or CsH (both at 1 pg/ml) . Total cellular RNA
was extracted and analyzed with various cDNA probes . Each lane contains 10 hg/ml ofRNA .
The autoradiograms were exposed for3 d (PFP, SE 1, SE 2, IT, and TNF) or for 8 h (actin) .
but not toPHA/PMA stimulation, and conversely, SE2responded well to PHA/PMA
treatment but only poorly to IL-2 stimulation . We also monitored the levels of two
cytokines : TNF and LT (Fig . 4). TNF mRNA increased weakly in response to
PHA/PMAtreatment, whereas LTmRNA was augmented in response to both IL-2
andPHA/PMA. For all fivemRNAs, addition of 1 pg/ml ofCsA, but not thenonim-
munosuppressive analogue CsH, partially abrogated the stimulatory effect of IL-2
andPHA/PMA(Fig . 4 and Table I) . The induction requirements for perforin and
TABLE I
Inhibitory Effect of CsA on Expression of Perform and SE
in Stimulated TLymphoblasts
The autoradiograms shown in Fig . 5 were scanned with a video densitometer .
The IL-2-induced signals were taken from the 10-h time point . The signals for
the indicated transcripts were normalized against the signal for actin. For deter-
mination ofpercent inhibition, the signals given by treated cells were compared
with those produced by untreated cells at time 0. The percent inhibition could





SE 1 14 ND
SE 2 60 65
TNF ND 79
LT 27 81SE mRNAs in Tblasts were in general similar to that observed with resident T cells
(data not shown).
We then compared the response of cells to PMA plus single stimuli with that to
the mAb OKT3, which specifically ligates the TCRCD3 complex. For T blasts,
PMA alone caused marked induction ofSE 2 mRNA but had no effect on perforin
and SE 1 mRNAs (Fig. 5). Lectin alone induced only the perforin mRNA to an
appreciable degree (twofold; data shown only forCon A in Fig. 5; similar observa-
tions were observed with PHA, data not shown). On the other hand, the combina-
tion ofPMA and lectin had a synergistic effect on both perforin and SE 2 mRNAs;
in most cases SE 2 mRNA was induced strongly by this treatment (190-fold in the
experiment shown in Fig. 5). SE 1 mRNA responded poorly to PMA plus lectin
(in Fig. 5, there was no increase at all).
The mitogenic OKT3 mAbhad either noor very little independent effect on any
ofthemRNAs westudied whenused alone, butwas markedly synergistic with PMA



















Effect ofmitogens on mRNA levels ofper-
forin and SE in T lymphoblasts. PHA-primed T lym-
phoblasts were stimulated for 24 h with the indicated
reagents before RNA blot analysis. PMA was used at
10 ng/ml and Con A at 10 jig/mi. OKT3 and adherent
accessory cells were used as described in Materials and
Methods. Densitometric scanning was performed on the
hybridization signals obtained from the RNA blots. The
signals for perforin, SE 1, and SE 2 were normalized
against that for actin. The signal ratios obtained for time
0 were assigned to equal unity. For SE 2, the signal for
PMA/Con A was 190-fold over control.2112
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1, and SE 2mRNAs (Fig . 5). Essentially similar resultswere obtained with unprimed
T cells (data not shown) .
A dose-response experiment was performed to establish the effective dose ofCsA
in blocking induction of the three specific mRNAs studied here . For T blasts, as
little as 30 ng/ml of CsA, added in the presence ofPMA and Con A, produced a
partial inhibitory effect on the induction of all threemRNAs (Fig. 6) . CsA partially
inhibited themRNAs increase mediated byPMA/ConA. At0.9 hg/ml, forexample,
CsAblocked20-59 1 7o (range forthe three mRNAs) oftheinduction response. Similar
inhibitory effects ofCsA were observed with unprimed T cells (not shown) . In the
case of rIL-2, a partial inhibitory effect of CsA for all three mRNAs could be ob-
served at 12, 24, and 48 h after stimulation (Fig . 7; data shownonly for restingPBL) .
Thus, at 48 h of stimulation with IL-2, for example, the mRNA increase for per-
forin, SE 1, and SE 2 was inhibited 43, 55, and 55%, respectively, by CsA .
mRNA Levels in T4 and T8 Subsets.
￿
Highly enriched populations ofT8 - , T4- ,
and OKMl -T4- cells were prepared by negative selection using a panning tech-
nique and were stimulated with various mitogens (Fig. 8 ; data shown only forIL-2) .
Panningwith OKM1 removes precursors ofNK and/or lymphokine activated killer
(LAK) cells that are capable of killing K562 targets (J . W . Young, manuscript in
preparation) . OKMI -T4--depleted T8 + cells accounted for most of themRNA in-
crease induced by IL-2 (Fig . 8) . The signal associated with OKMI"T4- cells could
not be attributed to contaminating NK cells since undetectable levels of OKMl +
cells were observed in the final preparations . Maximally stimulated T8- (mainly
T4+) cells also expressed a small amount of perforin and SE (particularly SE 1)
mRNAs . In preliminary experiments, T8-OKMl - cells (>99% T4+) also presented
measurable levels ofperforinand SE mRNAsupon stimulation with IL-2 (not shown) .
Similar results were observed when negatively selected T cells ofT4 or T8 pheno-
FIGURE 6 .
￿
Dose dependence of the inhibi-
tory effect ofCsAon induction ofperforin and
SEmRNAs in PHA-primedTlymphoblasts.
Tlymphoblasts were stimulated withConA
(10 ;4g/ml) and PMA (10 ng/ml) for 24 h in
the absence or presence of CsA at the indi-
cated concentrations. Total cellular RNA (10
ug per lane) was analyzed with the cDNA
probes specific for PFP/perforin, SE 1, SE 2,
and actin .The autoradiograms were exposed





Inhibitory effect of CsA on induction of per-
forin and SE mRNAs in restingT lymphocytes. Human
monocyte-depleted PBL were stimulated with rIL-2 (100
U/ml) for 12, 24, and 48 h in the absence or presence of
CsA at 1 ug/ml . Theautoradiograms were exposed for 3 d .
FIGURE 8 .
￿
Differential expression of perforin and SE tran-
scripts in various T cell subsets . Human peripheral blood T
lymphocytes were separated into T4 - , T8 - , T4 -OKMl -
populations by negative selection usinga panning technique .
The cells were cultured with or without rIL-2 (100 U/ml) for
24 h before being processed for RNA blot analysis . The au-
toradiograms were exposed for 3 d .
types were stimulated with PMA/lectin (data not shown) . That is, induction of all
threemRNAs occurred mainly in T cells of the T8 phenotype, while T8-T4 + cells
produced low but measurable levels of those same mRNAs .
Discussion
The role of perforin and SE in mediating cytotoxicity has not been settled, in
part because the distribution ofthesemediators in primary erectorlymphocyte popu-
lations is virtually unknown . The lack ofknowledge on these mediators is more evi-
dent in thehuman system, since there is onlyalimited amount ofbiochemical infor-
mation on human perforin (2, 24, 25) and SE (26-28), when compared with the
much more detailed analyses with murine cells (reviewed in references 13-16) . Human
peripheral blood T cells represent an attractive model for studying granule medi-2114
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ators because large numbers of cells can easily be obtained and because much is
known about the induction of a number oflymphokine and other growth-related
mRNAs after polyclonal stimulation. Using cDNA probes specific for human per-
forin and two SE mRNAs, we studied their modulation in unprimed and primed
Tcellsin response toseveral Tcellmitogens. Wefound thatthe stimulation ofresting
Tcells, or therestimulation oflymphoblasts, inducesthe formation ofthese specific
mRNAs. Four parameters were monitored: stimuli, lymphocyte subsets, kinetics,
and effect of CsA.
Unprimed T cells in general did not producemeasurable levels ofthese mRNAs.
However, in a small number of unprimed T cell preparations used in our study,
we were able to detect low levels of perforin and SE mRNAs. Optimal mRNA in-
duction required the concerted action ofPMA and one ofthree other stimuli used:
lectin, OKT3 mAb, or accessory cells. There was little and sometimes no increase
in perforin and SE (1 and 2)mRNAs whenthe T cells were triggeredindependently
bylectin, PMA, OKT3, or accessorycells. The requirement forPMA plus a mitogen
(OKT3 orlectin) for optimalpolyclonal activation is consistent with previously pub-
lished results that suggest the need for two or more signals for resting lymphocytes
to become active and proliferation competent (see reference 29 for review). We no-
ticed that accessory cells could substitute effectively for PMA when used in combi-
nation with lectin or OKT3. These findings are similar to the stimulation require-
ments for lymphokine gene expression in T cells (30).
IL-2 alone, on the other hand, markedly induced the expression of perforin and
SE 1, and, to alesser degree, SE2. NKand LAKcells areknown toresponddirectly
to IL-2 with enhanced lymphokine production, cytotoxicity, and proliferation (31).
However, our results show that resting, unprimed T cells depleted of NK/LAK
precursors using the OKM1 mAb responded promptly to IL-2 with enhanced per-
forin, SE 1, and SE 2 mRNA accumulation.
Among T cells, the T8 (CD8) subset appeared to be mainly responsible for per-
forin and SE production. However, we have consistently detected perforin and SE
mRNAs intheT4 (CD4) subset in different experiments (data shown here and un-
published observations). Since perforin was also detected in a cloned CD4+ lym-
phocyte cell line (HUT78; Fig. 1), it is possible that perforin may indeed be pro-
duced by a subpopulation of CD4', class II MHC-restricted CTL (32, 33).
With regard to kinetics, the induction of perforin, SE 1, and SE 2 mRNAs in
both primed and unprimed Tcells appeared earlier with the IL-2 treatment than
with the treatment with PMA plus lectin, OKT3 mAb, or accessory cells. IL-2 was
a more effective inducer than PMA/lectin . The early mRNA induction effect pro-
duced by IL-2 is consistent with the time course of induction observed with other
lymphokine mRNAs(34-37). This inductioneffect is probablynotmediated through
the IL-2-R chain P55, since this chain is not expressed on resting T cells (38); and
in our studies, the p55 mRNA appeared much later than the perforin/SE signals
(S. Rafii, unpublished observations).
Theonset ofthePMA response involveslikely activation ofproteinkinase C, which
has been suggested before to play a direct role in T cell activation (39, 40) and in
CTL function (41).
The profound immunosuppressive effects ofCsA on T cells are well known andappear to be explained in part by its inhibitory activity on lymphokine gene tran-
scription (21, 30, 42-46). CsA isknown to selectively inhibit T cell activation medi-
ated by some but not all mitogens (46, 47). We obtained only a partial abrogation
ofmRNA levels in Tcells that have been challenged with IL-2 or PMA/lectin in
the presence ofCsA. It should be noted that we consistently observed an inhibitory
effect ofCsAonIL-2-mediated induction ofperforin and SEmRNAsin bothprimed
and unprimed T cell populations. This is a surprising finding, since CsA is largely
ineffective on IL-2-mediated induction of IFN-y and IL-2-R mRNAs (reviewed in
reference 46).
The findings presented here do not address the question ofwhether perforin and
SE are directly involved in cell-mediated killing. However, since perforin and SE
mRNAs are increased by mitogenic signals known to induce cytotoxic function, it
appears that these transcripts are modulated in T cells in a fashion appropriate for
a killing role. Experiments are presently being designed to further analyze the ex-
pression and control of these genes in stimulated T cells.
Summary
A pore-forming protein (PFP; perforin) and various serine esterases (SE) have
been identified in the cytoplasmic granules ofCTL and NK cells. Perforin and sev-
eral SE have recently been cloned. Northern blotting analysis was performed here
usingcDNAprobes specific forhumanperforin andtwo SE(SE 1/HS and SE2/GB)
to monitor the levels of specific mRNAs in mitogen-stimulated primary human T
cells. These mRNAs were rapidly induced by IL-2 with optimal responses at 300
U/ml. After IL-2 treatment, mRNAs for perforin, SE 1, and SE 2 peaked at 12-24
h and decreased after 48 h. The three mRNAs were also induced in T cells treated
with acombination ofPMA pluslectin, OKT3 mAb, orplastic-adherent accessory
cells. However, the induction induced by PMA/mitogen followed a slower kinetics,
peaking at 48 h. In general, we found that SE 1 mRNA was more readily induced
by IL-2, while SE 2 responded better to PMA/mitogen. Similar patterns ofmRNA
expression were observed forboth unprimed Tcells and PHA-primed Tblasts. After
stimulation with IL-2 and PMA/mitogen, the T8+ subset was shown to be the main
producer ofperforin, SE 1, and SE 2. Low levels ofall three mRNAs, however, were
also detected in the T4' subset. The induction ofall three mRNAs by either IL-2
orPMA/mitogen was partiallyblocked by theimmunosuppressivedrug cyclosporin
A (CsA), but notby thebiologically inactive analogue cyclosporin H. Together, these
resultspointto some similarities and differences withupregulation ofgranule medi-
atormRNAs relative tolymphokine mRNAs. Both sets ofgenes require two signals
for their induction by mitogens. In contrast to lymphokines, there is a strong re-
sponse of granule mRNAs to IL-2, and the induction of these transcripts is only
partially blocked by CsA.
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